• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

头颈部孤立性大角化棘皮瘤:一项观察性研究。

Solitary Large Keratoacanthomas of the Head and Neck: An Observational Study.

作者信息

Rossi Anthony M, Park Brian, Qi Bernice, Lee Erica H, Busam Klaus J, Nehal Kishwer S

机构信息

*Department of Medicine, Dermatology Service, Memorial Sloan Kettering Cancer Center, New York, New York; †Weill Cornell Medicine, New York, New York; ‡Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York.

出版信息

Dermatol Surg. 2017 Jun;43(6):810-816. doi: 10.1097/DSS.0000000000001080.

DOI:10.1097/DSS.0000000000001080
PMID:28296794
Abstract

BACKGROUND

Solitary large keratoacanthomas (KAs) of the head and neck present a management dilemma, as no reliable means to predict the clinical course is available. Although typically considered a low-grade tumor, KAs are reported to invade/metastasize, prompting more aggressive treatment. There is little published regarding factors that predict when a KA behaves more like an aggressive squamous cell carcinoma (SCC).

OBJECTIVE

To study the clinical and pathologic features of large solitary head and neck KAs and assess response to intralesional methotrexate (IL-MTX) as well as predictors of clinical course.

MATERIALS AND METHODS

An observation study of 14 patients with large solitary head and neck KAs were treated with IL-MTX and then excised by Mohs micrographic surgery (MMS) at a later time point. Clinical presentation, treatment, response, and pathology were recorded. Features of classic KAs were compared with those with an aggressive SCC course.

RESULTS

Ten of fourteen lesions responded with necrosis, a decrease in size and/or pain, and histological clearance on MMS. However, 4/14 lesions continued to have progression despite IL-MTX therapy. These showed persistent pain, perineural invasion, moderate/poor differentiation, and an infiltrative growth.

LIMITATIONS

Small sample size.

CONCLUSION

Significant pain, or continued growth may suggest an underlying aggressive SCC in clinically classic large KAs. In these cases, surgical management with assessment for high-risk tumor features is recommended.

摘要

背景

头颈部孤立性大的角化棘皮瘤(KA)的治疗存在两难困境,因为目前尚无可靠方法来预测其临床病程。尽管KA通常被认为是低级别肿瘤,但有报道称其会发生侵袭/转移,这促使人们采取更积极的治疗方法。关于预测KA何时表现得更像侵袭性鳞状细胞癌(SCC)的因素,相关报道较少。

目的

研究头颈部孤立性大KA的临床和病理特征,评估病灶内注射甲氨蝶呤(IL-MTX)的疗效以及临床病程的预测因素。

材料与方法

对14名头颈部孤立性大KA患者进行观察性研究,先采用IL-MTX治疗,随后在稍后时间点通过莫氏显微外科手术(MMS)切除。记录临床表现、治疗情况、疗效及病理结果。将典型KA的特征与具有侵袭性SCC病程的KA特征进行比较。

结果

14个病灶中有10个出现坏死、大小缩小和/或疼痛减轻,且在MMS时达到组织学清除。然而,14个病灶中有4个尽管接受了IL-MTX治疗仍持续进展。这些病灶表现为持续性疼痛、神经周围侵犯、中度/低分化以及浸润性生长。

局限性

样本量小。

结论

在临床典型的大KA中,明显疼痛或持续生长可能提示潜在的侵袭性SCC。在这些情况下,建议进行手术治疗并评估高危肿瘤特征。

相似文献

1
Solitary Large Keratoacanthomas of the Head and Neck: An Observational Study.头颈部孤立性大角化棘皮瘤:一项观察性研究。
Dermatol Surg. 2017 Jun;43(6):810-816. doi: 10.1097/DSS.0000000000001080.
2
Management of Keratoacanthoma: 157 Tumors Treated With Surgery or Intralesional Methotrexate.角化棘皮瘤的治疗:手术或瘤内注射甲氨蝶呤治疗 157 例肿瘤。
Dermatol Surg. 2019 Jul;45(7):877-883. doi: 10.1097/DSS.0000000000001739.
3
[Intralesional infusion of methotrexate as neoadjuvant therapy improves the cosmetic and functional results of surgery to treat keratoacanthoma: results of a randomized trial].[病灶内注射甲氨蝶呤作为新辅助治疗可改善手术治疗角化棘皮瘤的美容和功能效果:一项随机试验的结果]
Actas Dermosifiliogr. 2011 Oct;102(8):605-15. doi: 10.1016/j.ad.2011.03.013. Epub 2011 Jul 13.
4
Treatment of Solitary Keratoacanthoma of the Nose With Intralesional Methotrexate and Review of the Literature.鼻孤立性角化棘皮瘤的病灶内注射甲氨蝶呤治疗及文献综述
J Drugs Dermatol. 2019 Jul 1;18(7):693-696.
5
Multiple keratoacanthomas occurring in surgical margins and de novo treated with intralesional methotrexate.手术切缘出现多个角化棘皮瘤,并采用病灶内注射甲氨蝶呤进行初次治疗。
Cutis. 2016 Dec;98(6):E12-E15.
6
Intralesional methotrexate versus 5-flurouracil in the treatment of keratoacanthoma.局部注射氨甲喋呤与 5-氟尿嘧啶治疗角化棘皮瘤的疗效比较。
Arch Dermatol Res. 2024 Jun 15;316(7):400. doi: 10.1007/s00403-024-03139-1.
7
Intralesional methotrexate treatment for keratoacanthoma tumors: a retrospective study and review of the literature.皮损内注射甲氨蝶呤治疗角化棘皮瘤:一项回顾性研究及文献综述
J Am Acad Dermatol. 2007 Jun;56(6):989-93. doi: 10.1016/j.jaad.2006.12.017.
8
Cutaneous head and neck melanoma treated with Mohs micrographic surgery.采用莫氏显微外科手术治疗的头颈部皮肤黑色素瘤。
J Am Acad Dermatol. 2005 Jan;52(1):92-100. doi: 10.1016/j.jaad.2004.08.038.
9
Two perplexing skin tumors: microcystic adnexal carcinoma and keratoacanthoma.两种令人困惑的皮肤肿瘤:微囊性附属器癌和角化棘皮瘤。
Ann Otol Rhinol Laryngol. 1994 Oct;103(10):829-32. doi: 10.1177/000348949410301016.
10
Intralesional methotrexate as effective treatment in solitary giant keratoacanthoma of the lower lip.病灶内注射甲氨蝶呤有效治疗下唇孤立性巨大角化棘皮瘤。
Dermatology. 2000;200(4):317-9. doi: 10.1159/000018395.

引用本文的文献

1
Intralesional Treatments for Invasive Cutaneous Squamous Cell Carcinoma.侵袭性皮肤鳞状细胞癌的瘤内治疗
Cancers (Basel). 2023 Dec 28;16(1):158. doi: 10.3390/cancers16010158.
2
Topical Imiquimod 5% as a Treatment Option in Solitary Facial Keratoacanthoma.局部使用5%咪喹莫特作为孤立性面部角化棘皮瘤的一种治疗选择。
Open Access Maced J Med Sci. 2018 Mar 8;6(3):531-535. doi: 10.3889/oamjms.2018.133. eCollection 2018 Mar 15.